Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring

Psycho-Oncology

Volumn 11, Issue 5, 2002, Pages 401-414

  Green, Heather J ^a   Pakenham, Kenneth I ^a   Headley, Betty C ^b   Gardiner, Robert A ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE; GONADORELIN DERIVATIVE; GOSERELIN; LEUPRORELIN; STEROID;

ADULT; AGED; ARTICLE; BEHAVIOR MODIFICATION; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CLINICAL TRIAL; COGNITION; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DRUG MONITORING; EMOTIONAL STRESS; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALE SEXUAL DYSFUNCTION; NEUROLOGIC DISEASE; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT SATISFACTION; PHYSICAL DISEASE; PROSTATE CANCER; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL CARE; PSYCHOSOCIAL DISORDER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REGRESSION ANALYSIS; ROLE PLAYING; SOCIAL LIFE; SYMPTOM; THREAT;

ADAPTATION, PSYCHOLOGICAL; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; CYPROTERONE ACETATE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; IMPOTENCE; LEUPROLIDE; MALE; MIDDLE AGED; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SICK ROLE;

EID: 0036746659     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.599     Document Type: Article

References (48)

1. Aaronson NK, Ahmedzai S, Bergman B et al., The European Organization for Research and Treatment of Cancer Study Group on Quality of Life. 1993. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376.
2. Albertsen PC, Aaronson NK, Muller MJ et al. 1997. Health-related quality of life among patients with metastatic prostate cancer. Urology 49: 207-217.
3. Altwein J, Ekman P, Barry M et al. 1997. How is quality of life in prostate cancer patients influenced by modern treatment? The Wallenberg Symposium. Urology 49 (Suppl. 4A): 66-76.
4. Australian Bureau of Statistics. Australian Standard Classification of Occupations (ASCO) (2nd edn). Australian Bureau of Statistics: Canberra, Australia, 1997.
5. Bjorck JP, Hopp DP, Jones LW. 1999. Prostate cancer and emotional functioning: Effects of mental adjustment, optimism, and appraisal. J Psychosoc Oncol 17: 71-85.
6. Bloom JR. 1996. Social support of the cancer patient and the role of the family. In Cancer and the Family, Baider L, Cooper CL, Kaplan De-Nour A (eds.). John Wiley and Sons: New York; 53-70.
7. Borghede G, Sullivan M. 1996. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res 5: 212-222.
8. Bowling A. 1991. Measuring Health: A review of Quality of Life Measurement Scales. Open University Press: Buckingham.
9. Burgess ES, Haaga DAF. 1998. Appraisals, coping responses, and attributions as predictors of individual differences in negative emotions among pediatric cancer patients. Cognitive Ther Res 22: 457-473.
10. Burman ME, Weinert C. 1997. Concerns of rural men and women experiencing cancer. Oncol Nurs Forum 24: 1593-1600.
11. Carver CS, Scheier MF, Weintraub JK. 1989. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol 56: 267-283.
12. Cassileth BR, Soloway MS, Vogelzang NJ et al. members of the Zoladex Prostate Cancer Study Group. 1992. Quality of life and psychosocial status in stage D prostate cancer. Qual Life Res 1: 323-330.
13. Clark JA, Wray N, Brody B et al. 1997. Dimensions of quality of life expressed by men treated for metastatic prostate cancer. Soc Sci Med 45: 1299-1309.
14. Colvin CR, Block J, Funder DC. 1995. Overly positive self-evaluations and personality: Negative implications for mental health. J Pers Soc Psychol 68: 1152-1162.
15. da Silva FC, Fossa SD, Aaronson NK et al. The members of the EORTC Genitourinary Tract Cancer Cooperative Group. 1996. The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC clinical trial 30853. Eur J Cancer 32A: 72-77.
16. Daneshgari F, Crawford ED. 1993. Endocrine therapy of advanced carcinoma of the prostate. In Cancer of the Prostate, Das S, Crawford ED (eds.). Marcel Dekker: New York; 333-354.
17. Esper P, Redman BG. 1999. Supportive care, pain management, and quality of life in advanced prostate cancer. Urol Clin North Am 26: 375-389.
18. Fayers P, Aaronson N, Bjordal K, Sullivan M. 1997. EORTC QLQ-C30 Scoring Manual (revised). EORTC Study Group on Quality of Life: Brussels.
19. Folkman S, Greer S. 2000. Promoting psychological well-being in the face of serious illness: When theory, research and practice inform each other. Psychooncology 9: 11-19.
20. Fryndenberg M, Giles GG, Mameghan H et al. 2000. Prostate cancer in Victoria in 1993: Patterns of reported management. Med J Aust 172: 270-274.
21. Garnick MB, Fair WR. 1996. Prostate cancer: Emerging concepts. Part I. Ann Intern Med 125: 118-125.
22. Glanz K, Lerman C. 1992. Psychosocial impact of breast cancer: A critical review. Ann Behav Med 14: 204-212.
23. Gleason PP, Schulz R. 1996. Assessing pharmacotherapy outcomes: A model for clinicians. Pharmacotherapy 16: 1142-1153.
24. Green HJ, Pakenham KI, Headley BC et al. 2001. Cognitive impairment in men treated with hormonal medication for prostate cancer: A randomized controlled trial. Manuscript submitted for publication.
25. Herr HW, O'Sullivan M. 2000. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol 163: 1743-1746.
26. Hinton-Bayre AD, Geffen GM, Geffen LB, McFarland K, Friis P. 1999. Concussion in contact sports: Reliable change indices of impairment and recovery. J Clin Exp Neuropsychol 21: 70-86.
27. Holahan CJ, Moos RH, Schaefer JA. 1996. Coping, stress resistance, and growth: conceptualising adaptive functioning. In Handbook of Coping: Theory, Research, Application, Zeidner M, Endler NS (eds.). John Wiley and Sons: New York; 24-43.
28. Huben RP. 1992. Hormone therapy of prostatic bone metastases. In Prostate Cancer and Bone Metastasis, Karr JP, Yamanaka H (eds.). Plenum Press: New York; 305-316.
29. Isurugi K, Fukutani K, Ishida H, Hosoi Y. 1980. Endocrine effects of cyproterone acetate in patients with prostatic cancer. J Urol 123: 180-184.
30. Jacobson NS, Truax P. 1991. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59: 12-19.
31. Jain SK. 1994. Trends in Mortality: By causes of Death in Australia, the States and Territories during 1971-92, and in Statistical Divisions and Sub-divisions during 1991-92. National Centre for Epidemiology and Population Health; Australian Bureau of Statistics: Canberra, Australia.
32. Johnson JE, Fieler VK, Wlasowicz GS et al. 1997. The effects of nursing care guided by self-regulation theory on coping with radiation therapy. Oncol Nurs Forum 24: 1041-1050.
33. Krongrad A, Granville LJ, Burke MA et al. 1997. Predictors of general quality of life in patients with benign prostate hyperplasia or prostate cancer. J Urol 157: 534-538.
34. Landis SH, Murray T, Bolden S, Wingo PA. 1998. Cancer statistics, 1998. CA Cancer J Clin 48: 6-29.
35. Lazarus RS, Folkman S. 1984. Stress, Appraisal and Coping. Springer Publishing: New York.
36. Lovibond PF, Lovibond SH. 1995. The structure of negative emotional states: Comparison of the depression anxiety stress scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 33: 335-343.
37. O'Rourke ME, Germino BB. 1998. Prostate cancer treatment decisions: A focus group exploration. Oncol Nurs Forum 25: 97-104.
38. Osowiecki D, Compas BE. 1998. Psychological adjustment to cancer: Control beliefs and coping in adult cancer patients. Cognitive Ther Res 22: 483-499.
39. Parle M, Maguire P. 1995. Exploring relationships between cancer, coping, and mental health. J Psychosoc Oncol 13: 27-50.
40. Pavot W, Diener E. 1993. Review of the Satisfaction With Life Scale. Psychol Assess 5: 164-172.
41. Rossetti SR, Terrone C. 1996. Quality of life in prostate cancer patients. Eur Urol 30 (suppl 1): 44-48.
42. Seidenfeld J, Samson DJ, Hasselblad V et al. 2000. Single-therapy androgen suppression in men with advanced prostate cancer: A systematic review and meta-analysis. Ann Intern Med 132: 566-577.
43. Silveira JM, Winstead-Fry P. 1997. The needs of patients with cancer and their caregivers in rural areas. Oncol Nurs Forum 24: 71-76.
44. Stanton AL, Danoff-Burg S, Cameron CL, Ellis AP. 1994. Coping through emotional approach: Problems of conceptualisation and confounding. J Pers Soc Psychol 66: 350-362.
45. Steele RG, Fitch MI. 1996. Needs of family caregivers of patients receiving home hospice care for cancer. Oncol Nurs Forum 23: 823-828.
46. Tabachnick BG, Fidell LS. Using Multivariate Statistics (2nd edn). Harper Collins: New York, 1989.
47. Tannock IF, Osaba D, Stockler MR et al. 1996. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points. J Clin Oncol 14: 1756-1764.
48. van Andel G, Kurth KH, de Haes JCJM. 1997. Quality of life in patients with prostatic carcinoma: A review and results of a study in N+ disease. Prostate-specific antigen as a predictor of quality of life. Urol Res 25 (Suppl. 2): S79-S88.